D-0412-2018 Class III Terminated
FDA drug recall D-0412-2018 was initiated by AbbVie Inc. on Jan 22, 2018 and is designated Class III. Reason for recall: Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage. The recall status is terminated (terminated Sep 13, 2018). Affected quantity: 7,770 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2018
- Initiation Date
- Jan 22, 2018
- Termination Date
- Sep 13, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,770 bottles
Product description
Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
Reason for recall
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Distribution pattern
MS, OH
Code information
Lot #: 1088856, Exp 6/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0412-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.